Contact a Personal Injury Lawyer
Photo of Philadelphia skyline


On February 26, 2009 the FDA forced the manufacturers of Reglan, (metoclopramide) a drug used to treat gastrointestinal disorders, to add a black-box warning about the risk of tardive dyskinesia, a condition which includes involuntary, uncontrollable and repetitive movements of the body.

Reglan is a prescription drug used to treat gastrointestinal problems, mainly gastroesophageal reflux disease (GERD). Reglan is currently being prescribed for children and adults. In addition, patients undergoing cancer treatments may be given Reglan to reduce nausea and vomiting. Infants are commonly given Reglan to treat gastrointestinal problems.

Evidence shows that Reglan can cause Tardive Dyskinesia (TD), a serious and often irreversible movement disorder. Patients with TD suffer from abnormal and uncontrollable muscle movements, which can affect the muscles of the legs, arms, feet, hands, abdomen, shoulders, neck, face, mouth, tongue and eyes. Presently, there is no known treatment for TD. In some cases, the disorder may disappear or symptoms may be reduced weeks or even months after a patient stops taking Reglan. In some cases, however, the damage is permanent and irreversible.

If you, or someone you know, experienced tardive dyskinesia or any other Reglan side-effect, contact us today for a free consultation at (800) 220-5291. You may also click here to fill out our "Do I have a case form". A representative from our office will contact you directly.

This informational piece was prepared by Silverman & Fodera. If you would like more information on this topic, call us at (800) 220-LAW1, or use the "Do I Have A Case?" link on this web site.